We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.46%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$640M
Cap. Flow
+$72.3M
Cap. Flow %
0.39%
Top 10 Hldgs %
10.88%
Holding
2,903
New
146
Increased
740
Reduced
905
Closed
305

Top Buys

Rank Stock Value
1
TT icon
Trane Technologies
TT
+$81.7M
2
BA icon
Boeing
BA
+$67.3M
3
ATVI
Activision Blizzard
ATVI
+$59.4M
4
UNH icon
UnitedHealth
UNH
+$58.1M
5
SYY icon
Sysco
SYY
+$47.3M

Top Sells

Rank Stock Value
1
KR icon
Kroger
KR
+$88.6M
2
WAB icon
Wabtec
WAB
+$57.7M
3
LUV icon
Southwest Airlines
LUV
+$57.2M
4
HON icon
Honeywell
HON
+$56.3M
5
ORLY icon
O'Reilly Automotive
ORLY
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Financials 14.04%
3 Healthcare 12.9%
4 Industrials 11.58%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMI icon
976
Valmont Industries
VMI
$9.44B
$300K ﹤0.01%
2,138
+50
+2% +$6.94K
ZLTQ
977
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$300K ﹤0.01%
+6,907
New +$278K
MORN icon
978
Morningstar
MORN
$6.56B
$298K ﹤0.01%
4,066
+100
+3% +$7.35K
ENB icon
979
Enbridge
ENB
$124B
$297K ﹤0.01%
7,071
+2,550
+56% +$109K
RLI icon
980
RLI Corp
RLI
$5.68B
$297K ﹤0.01%
9,424
+5,200
+123% +$161K
WLKP icon
981
Westlake Chemical Partners
WLKP
$777M
$297K ﹤0.01%
13,750
+2,980
+28% +$64K
IYW icon
982
iShares US Technology ETF
IYW
$23.7B
$296K ﹤0.01%
9,880
-2,000
-17% -$59.6K
NS
983
DELISTED
NuStar Energy L.P.
NS
$295K ﹤0.01%
5,962
+2,600
+77% +$124K
CNP icon
984
CenterPoint Energy
CNP
$29.1B
$293K ﹤0.01%
11,904
+51
+0.4% +$1.19K
FCX icon
985
Freeport-McMoran
FCX
$90B
$293K ﹤0.01%
22,324
-1,562
-7% -$20K
ITCI
986
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$292K ﹤0.01%
19,410
+11,762
+154% +$166K
PGNX
987
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$292K ﹤0.01%
+33,907
New +$251K
KYO
988
DELISTED
Kyocera Adr
KYO
$292K ﹤0.01%
5,913
-142,364
-96% -$6.95M
BF.A icon
989
Brown-Forman Class A
BF.A
$12.3B
$290K ﹤0.01%
7,873
LXRX icon
990
Lexicon Pharmaceuticals
LXRX
$1.02B
$290K ﹤0.01%
+20,985
New +$337K
SENS icon
991
Senseonics Holdings Inc
SENS
$254M
$289K ﹤0.01%
5,428
PLOW icon
992
Douglas Dynamics
PLOW
$1.07B
$287K ﹤0.01%
8,546
TFSL icon
993
TFS Financial
TFSL
$5.1B
$285K ﹤0.01%
15,000
GNBC
994
DELISTED
Green Bancorp, Inc
GNBC
$285K ﹤0.01%
18,800
BIDU icon
995
Baidu
BIDU
$35.8B
$284K ﹤0.01%
1,733
-37
-2% -$6.3K
SWN
996
DELISTED
Southwestern Energy Company
SWN
$283K ﹤0.01%
26,206
+10,650
+68% +$122K
SHLX
997
DELISTED
Shell Midstream Partners, L.P.
SHLX
$282K ﹤0.01%
+9,700
New +$270K
MITSY
998
DELISTED
MITSUI & CO LTD ADR (US)
MITSY
$282K ﹤0.01%
1,026
-15
-1% -$4.12K
IEV icon
999
iShares Europe ETF
IEV
$1.63B
$281K ﹤0.01%
7,250
-1,395
-16% -$53.2K
MFC icon
1000
Manulife Financial
MFC
$72.6B
$281K ﹤0.01%
15,805
+4,340
+38% +$70.7K

Similar funds

Glenmede Trust's Q4 2016 Portfolio in Review

As of Q4 2016, Glenmede Trust held 2,903 positions worth $18.4B, up 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust's Q4 2016 filing shows 146 new, 740 increased, 905 reduced and 305 closed positions. Its largest new stake was CACI: 324,090 shares worth $40.3M. The largest sale was Kroger, an estimated $88.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2016 buy was CACI: 324,090 shares worth $40.3M.
  • Glenmede Trust added most to Trane Technologies in Q4 2016, an estimated $81.7M increase.
  • Glenmede Trust's biggest Q4 2016 reduction was Kroger, cutting an estimated $88.6M.
  • Glenmede Trust fully exited Tutor Perini Cor in Q4 2016, selling an estimated $7.9M.
  • Glenmede Trust's ten largest holdings make up 11% of its $18.4B portfolio in Q4 2016.
  • Glenmede Trust opened 146 new positions and closed 305 in Q4 2016.
  • Glenmede Trust's portfolio value rose 3.6% quarter-over-quarter to $18.4B.

Based on Glenmede Trust's 13F filing for Q4 2016, filed 14 Feb 2017.